The purpose of this study is to isolate and measure circulating tumor cells in the blood stream to advance detection of cancer and treatment monitoring. In this study, the investigators will utilize the novel technology for circulating tumor cell detection in order to evaluate their presence in patients with lung cancer.
The plan is to collect both blood and tumor samples from the patient's lung cancer in order to validate this technology in detecting circulating tumor cells. The investigators will also obtain a postoperative blood sample to see if there is a decrease in the overall circulating tumor cell measurement once the tumor has been surgically removed.
Study Type
OBSERVATIONAL
Enrollment
23
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Number and types of mutations in the primary tumor.
Time frame: Within 1 year
Number and type of mutations detectable in the matched circulating tumor cell samples.
Time frame: Within 1 year
Concordance of mutations detected by either method.
Time frame: Within 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.